Chemotherapy Induced Nausea and Vomiting : Episode 7

Improving Compliance in CINV

Jul 28, 2016

James Natale, PharmD, BCOP, highlights practical considerations for improving medication adherence in chemotherapy-induced nausea and vomiting.

Related Videos

Related Content

FDA Approves Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

January 28th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

January OTC Case Studies- Diabetes

January 27th 2023

FDA Approves Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

January 28th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

January OTC Case Studies- Diabetes

January 27th 2023

FDA Approves Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

January 28th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

January OTC Case Studies- Diabetes

January 27th 2023

Related Content

FDA Approves Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

January 28th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

January OTC Case Studies- Diabetes

January 27th 2023

Recent Content

View More Recent Content

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.